Literature DB >> 3725323

Silicone oil for advanced proliferative vitreoretinopathy.

M S Cox, M T Trese, P L Murphy.   

Abstract

Repeated vitreous microsurgery followed by silicone oil injection was performed on a consecutive series of 51 patients with retinal detachment and advanced proliferative vitreoretinopathy who were not cured by previous conventional management, including vitrectomy, membrane peeling, gas tamponade, and scleral buckling. Anatomic reattachment was achieved in 65% of these cases. Ambulatory or better vision was restored in 74% of the anatomically successful cases. The silicone oil was removed from 30% of the eyes with complete attachment of the retina posterior to the buckle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3725323     DOI: 10.1016/s0161-6420(86)33686-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Vitrectomy with silicone oil infusion in severe diabetic retinopathy.

Authors:  A Castellarin; R Grigorian; N Bhagat; L Del Priore; M A Zarbin
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Efficacy and safety of heavy silicone oil Densiron 68 in the treatment of complicated retinal detachment with large inferior retinectomy.

Authors:  Sylvain Auriol; Véronique Pagot-Mathis; Laurence Mahieu; Claudia Lemoine; André Mathis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-28       Impact factor: 3.117

3.  A model of chronic hypotony in the rabbit.

Authors:  H C Kim; A Hayashi; A Shalash; E de Juan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-01       Impact factor: 3.117

4.  Intraocular pressure changes following the use of silicone oil or Densiron 68 as endotamponade in pars plana vitrectomy.

Authors:  Mario R Romano; Martina Angi; Vito Romano; Francesco Parmeggiani; Claudio Campa; Xavier Valldeperas; Ciro Costagliola
Journal:  Clin Ophthalmol       Date:  2010-11-26

5.  Postvitrectomy hypotonia: the role of the vitreous and retinochoroidal lesions.

Authors:  H D Schubert; K Kuang; J Fischbarg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

6.  Regular silicone and fluorosilicone oil in the prevention of retinal detachment caused by experimental proliferative vitreoretinopathy.

Authors:  A Alghadyan; G A Peyman; C Fizer; M Tawakol; K R Liu; B Yue; J H Peace
Journal:  Int Ophthalmol       Date:  1988-01       Impact factor: 2.031

7.  Vitreon, a short-term vitreoretinal tamponade.

Authors:  K J Blinder; G A Peyman; U R Desai; N C Nelson; W Alturki; C L Paris
Journal:  Br J Ophthalmol       Date:  1992-09       Impact factor: 4.638

8.  Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications.

Authors:  U Stolba; S Binder; M Velikay; P Datlinger; A Wedrich
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

9.  The combined use of perfluorohexyloctane (F6H8) and silicone oil as an intraocular tamponade in the treatment of severe retinal detachment.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Claudia Belting
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-21       Impact factor: 3.117

10.  Silicone oil removal: post-operative complications.

Authors:  Reda Issa; Tian Xia; Marco A Zarbin; Neelakshi Bhagat
Journal:  Eye (Lond)       Date:  2019-08-12       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.